Fibrinolytic inhibitors in off-pump coronary surgery: A prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo)

European Journal of Cardio-thoracic Surgery

Volumn 28, Issue 4, 2005, Pages 563-568

  Vanek, Tomas ^a   Jares, Martin ^a   Fajt, Richard ^a   Straka, Zbynek ^a   Jirasek, Karel ^a   Kolesar, Miroslav ^a   Brucek, Petr ^a   Maly, Marek ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

Author keywords

Aprotinin; Hemostasis; Off pump coronary artery bypass; Tranexamic acid

Indexed keywords

ANTIFIBRINOLYTIC AGENT; APROTININ; HEMOGLOBIN; TRANEXAMIC ACID;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; BRAIN EMBOLISM; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ENZYME ANALYSIS; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HEMOSTASIS; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; OFF PUMP CORONARY SURGERY; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SKIN INCISION; STATISTICAL SIGNIFICANCE;

AGED; ANTIFIBRINOLYTIC AGENTS; APROTININ; BLOOD LOSS, SURGICAL; CORONARY ARTERY BYPASS, OFF-PUMP; CREATINE KINASE; DOUBLE-BLIND METHOD; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEART DISEASES; HEMATOCRIT; HEMOGLOBINS; HEMOSTATICS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIUM; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; TRANEXAMIC ACID; TROPONIN I;

EID: 25144525008     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2005.06.027     Document Type: Article

References (25)

1. R.W. Barrons, and J.S. Jahr A review of post-cardiopulmonary bypass bleeding, aminocaproic acid, tranexamic acid, and aprotinin Am J Ther 3 1996 821 838
2. A. Laupacis, and D. Fergusson Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using peri-operative blood transfusion as the outcome. The international study of perioperative transfusion (ISPOT) investigators Anaesth Analg 85 1997 1258 1267
3. B.I. Wong, R.F. McLean, S.E. Fremes, K.A. Deemar, E.M. Harrington, G.T. Christakis, and B.S. Goldman Aprotinin and tranexamic acid for high transfusion risk cardiac surgery Ann Thorac Surg 69 2000 808 816
4. J.J. Andreasen, and C. Nielsen Prophylactic tranexamic acid in elective, primary coronary bypass surgery using cardiopulmonary bypass Eur J Cardiothorac Surg 26 2004 311 317
5. J.H. Levy Pharmacologic preservation of the hemostatic system during cardiac surgery Ann Thorac Surg 72 2001 S1814 S1820
6. G.J. Despotis, M.S. Avidan, and C.W. Hogue Jr Mechanisms and attenuation of hemostatic activation during extracorporeal circulation Ann Thorac Surg 72 2001 S1824 S1831
7. V. Casati, Ch. Gerly, A. Franco, G. Torri, A. D'Angelo, S. Benussi, and O. Alfieri Tranexamic acid in off-pump coronary surgery: a preliminary, randomized, double-blind, placebo-controlled study Ann Thorac Surg 72 2001 470 475
8. L. Englberger, P. Markart, F.S. Eckstein, F.F. Immer, P.A. Berdat, and T.P. Carrel Aprotinin reduces blood loss in off-pump coronary artery bypass (OPCAB) surgery Eur J Cardiothorac Surg 22 2002 545 551
9. M. Jares, T. Vanek, Z. Straka, and P. Brucek Tranexamic acid reduces bleeding after off-pump coronary artery bypass grafting J Cardiovasc Surg (Torino) 44 2003 205 208
10. V. Casati, P. Della Valle, S. Benussi, A. Franco, C. Gerli, P. Baili, O. Alfieri, and A. D'Angelo Effects of tranexamic acid in postoperative bleeding and related hematological variables in coronary surgery: comparison between on-pump and off-pump techniques J Thorac Cardiovasc Surg 128 2004 83 91
11. N.D. Nader, W.Z. Zhadra, N.T. Reich, D.R. Bacon, T.A. Salerno, and A.L. Panos Blood product use in cardiac revascularization: comparison of on- and off-pump techniques Ann Thorac Surg 68 1999 1640 1643
12. Z. Straka, P. Widimsky, K. Jirasek, P. Stros, J. Votava, T. Vanek, P. Brucek, M. Kolesar, and R. Spacek Off-pump versus on-pump coronary surgery: final results from a prospective randomized study PRAGUE-4 Ann Thorac Surg 77 2004 789 793
13. T.L. Frankel, S.C. Stamou, R.C. Lowery, E.I. Kapetanakis, P.C. Hill, E. Haile, and P.J. Corso Risk factors for hemorrhage-related reexploration and blood transfusion after conventional versus coronary revascularization without cardiopulmonary bypass Eur J Cardiothorac Surg 27 2005 494 500
14. T. Vanek, P. Brucek, and Z. Straka Fast track as a routine for open-heart surgery Eur J Cardiothorac Surg 21 2001 369
15. Z. Straka, P. Brucek, T. Vanek, J. Votava, and P. Widimsky Routine immediate extubation for off-pump coronary artery bypass grafting without thoracic epidural analgesia Ann Thorac Surg 74 2002 1544 1547
16. P.J. Brucek, Z. Straka, T. Vanek, and M. Jares Less invasive cardiac anesthesia: an ultra-fast-track procedure avoiding thoracic epidural analgesia Heart Surg Forum 6 2003 E107 E110
17. M. Levi, M.E. Cromheecke, E. de Jonge, M.H. Prins, B.J.M. de Mol, E. Briët, and H.R. Büller Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints Lancet 354 1999 1940 1947
18. P. Biglioli, A. Cannata, F. Alamanni, M. Naliato, M. Porqueddu, M. Zanobini, E. Tremoli, and A. Parolari Biological effects of off-pump vs. on-pump coronary artery surgery: focus on inflammation, hemostasis and oxidative stress Eur J Cardiothorac Surg 24 2003 260 269
19. K. Hekmat, T. Zimmermann, S. Kampe, S.M. Kasper, H.J. Weber, H.J. Geissler, and U. Mehlhorn Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial Curr Med Res Opin 20 2004 121 126
20. P.K. Smith, and L.H. Muhlbaier Aprotinin: safe and effective only with the full-dose regimen Ann Thorac Surg 62 1996 1575 1577
21. D.M. Cosgrove, B. Heric, B.W. Lytle, P.C. Taylor, R. Novoa, L.A.R. Golding, R.W. Stewart, P.M. McCarthy, and F.D. Loop Aprotinin therapy for reoperative myocardial revascularization - a placebo-controlled study Ann Thorac Surg 54 1992 1031 1038
22. J.H. Lemmer, E.W. Dilling, J.R. Morton, J.B. Rich, F. Robicsek, D.L. Bricker, C.B. Hantler, J.G. Copeland 3rd, J.L. Ochsner, P.O. Daily, C.W. Whitten, G.P. Noon, and R. Maddi Aprotinin for primary coronary artery bypass grafting: a multicenter trial of three dose regimens Ann Thorac Surg 62 1996 1659 1667
23. E.L. Alderman, J.H. Levy, J.B. Rich, M. Nili, B. Vidne, H. Schaff, G. Uretzky, G. Pettersson, J.J. Thiis, C.B. Hantler, B. Chaitman, and A. Nadel Analyses of coronary graft patency after aprotinin use: results from the international multicenter aprotinin graft patency experience (IMAGE) trial J Thorac Cardiovasc Surg 116 1998 716 730
24. J.H. Levy Efficacy and safety of aprotinin in cardiac surgery Orthopedics 27 2004 S659 S662
25. M. Mariani, Y. Gu, P. Boonstra, J.G. Grandjean, W. van Oeveren, and T. Ebels Procoagulant activity after off-pump coronary operation: is the current anticoagulation adequate? Ann Thorac Surg 67 1999 1370 1375